AzTrials
AzTrials

Cannabis UseNCT07496489

Perceptions of Proposed Warnings for Cannabis Edibles Packaging

A study testing Delayed Effects Text Only, Delayed Effects Plus Icon and Delayed Effects Plus Dose in people with Cannabis Use, run by Wake Forest University Health Sciences at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare a delayed-effects warning to an expanded warning developed in previous experiments on knowledge, harm perceptions, and willingness to try cannabis edibles. Additionally, this study will examine the effects of a corresponding icon on attention to and recall of the warning. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Cannabis Use
What is being tested?
Delayed Effects Text Only, Delayed Effects Plus Icon and Delayed Effects Plus Dose
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,250 participants
Where
1 siteUnited States
Study dates
27 May 2026to 21 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • English-speaking by self-selection
  • United States resident

Who cannot join

  • Already participated in a precursor project (IRB00104038, IRB000111438)
  • Eligible but demographic and user group strata have already been met

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157

Other trials in United States

About this study

Official title: Perceptions of Proposed Warnings for Cannabis Edibles Packaging (Cannabis Edibles Aim 2 Experiment)

The purpose of this study is to compare a delayed-effects warning to an expanded warning developed in previous experiments on knowledge, harm perceptions, and willingness to try cannabis edibles. Additionally, this study will examine the effects of a corresponding icon on attention to and recall of the warning.

Read the detailed description

Cannabis edibles are rapidly leading the legal recreational cannabis market. The Cannabis edibles present health harms that are not typical of smoked marijuana, including accidental overconsumption of high levels of THC. One effective way to communicate proper dosing and risks of overconsumptions is through package warnings. This experiment will assign participants to view real cannabis edibles packaging with one of four variations of warnings and a series of questions to assess knowledge, harm perceptions, and willingness to try the product shown. One group of participants will serve as the control and will see the same cannabis edibles packaging without a warning.

Conditions
Cannabis Use
Being tested
No Warning Control, Delayed Effects Text Only, Delayed Effects Plus Icon, Delayed Effects Plus Dose, Delayed Effects Plus Dose Plus Adverse Effects
Keywords
Cannabis, edibles, marijuana, marketing, packaging, warnings
Medical subject headings
Marijuana Abuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No Warning ControlBehavioural

    Participants in the control condition will see an edible cannabis package without a warning message.

  • Delayed Effects Text OnlyBehavioural

    Participants will see a cannabis edibles package with a warning message containing a delayed effects message.

  • Delayed Effects Plus IconBehavioural

    Participants will see a cannabis edibles package with a warning containing a delayed effects message and a corresponding icon.

  • Delayed Effects Plus DoseBehavioural

    Participants will view a cannabis edibles package with a warning containing delayed effects message and dosing instructions.

  • Delayed Effects Plus Dose Plus Adverse EffectsBehavioural

    Participants will view a cannabis edibles package with a warning containing delayed effects, dosing instructions, and adverse effects message.

Study groups in NCT07496489
Study groupRoleWhat they receive
No Warning ControlExperimentalOne cannabis edibles package without a warning message.
Receives: Behavioral: No Warning Control
Delayed Effects Text OnlyExperimentalOne cannabis edibles package with a warning containing a delayed effects message
Receives: Behavioral: Delayed Effects Text Only
Delayed Effects Plus IconExperimentalOne cannabis edibles package with a warning containing a delayed effects message and a corresponding icon.
Receives: Behavioral: Delayed Effects Plus Icon
Delayed Effects Plus DoseExperimentalOne cannabis edibles package with a warning containing delayed effects message and dosing instructions.
Receives: Behavioral: Delayed Effects Plus Dose
Delayed Effects Plus Dose Plus Adverse EffectsExperimentalOne cannabis edibles package with a warning containing delayed effects, dosing instructions, and adverse effects message.
Receives: Behavioral: Delayed Effects Plus Dose Plus Adverse Effects

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Product appeal score

    One item to assess the appeal of the product. Results will be reported as means.

    Question: How appealing is this edible to you? Response options: (0) Not at all appealing to (10) Very appealing. Higher score denoting more appeal

    Measured: Minute 1

  2. Perception of product safety score

    One item to assess the participants' perception of the safety of the product. Results will be presented as the frequency of each type of response.

    Question: How safe do you think it would be to eat this edible? Response options: (1) Not at all safe, (2) Slightly safe, (3) Somewhat safe, (4) Moderately safe, (5) Very safe. Higher score denoting more safe to eat

    Measured: Minute 1

  3. Perceived likelihood of experiencing unwanted effects score

    One item to assess the participants' perception of the likelihood of experiencing unwanted effects. Results will be presented as the frequency of each type of response.

    Question: How likely are you to experience unwanted effects if you eat this edible? Response options: (1) Not at all likely, (2) Slightly likely, (3) Somewhat likely, (4) Moderately likely, (5) Very likely. Higher score denoting greater likelihood of experiencing side effects

    Measured: Minute 1

  4. Interest in a free sample score

    One item to assess how interested a participant would be in a free sample of the product. Results will be presented as the frequency of each type of response.

    Question: How interested would you be in a free sample of this edible? Response options: (1) Not at all interested, (2) Slightly interested, (3) Somewhat interested, (4) Moderately interested, (5) Very interested. Higher score denoting more interest

    Measured: Minute 1

  5. Concern about the risks of overconsumption due to warning score

    One item to assess how much the warning makes the participant concerned about the risks of overconsumption for participants randomized to view a package with a warning (intervention conditions only). Results will be presented as the frequency of each type of response.

    Question: How much does this warning make you concerned about potential risks from eating too much of this edible? Response options: (1) Not at all, (2) A little, (3) Somewhat, (4) Quite a bit, (5) A great deal. Higher score denotes more concern

    Measured: Minute 1

  6. Improved understanding of safe consumption due to warning score

    One item to assess how much the warning gives the participant a better understanding of how to safely consume an edible (intervention conditions only). Results will be presented as the frequency of each type of response.

    Question: How much does this warning give you a better understanding of how to safely consume this edible? Response options: (1) Not at all, (2) a little, (3) somewhat, (4) quite a bit, (5) a great deal. Higher score denotes better understanding of safety

    Measured: Minute 1

Secondary outcomes (2)
  1. Warning recall

    One item to assess the participant's recall of a warning message on the package. Results will be presented as the percentage correctly selected.

    Question: Do you recall seeing a warning on the package we showed you earlier? Response Options: Yes, No

    Measured: Minute 1

  2. Attention Score

    One measure to assess the extent to which the warning grabbed the participant's attention. Asked of those who recall seeing a warning on the package. Results will be presented as frequency of each type of response.

    Question: How much did the warning grab your attention? Response options: (0) Not at all, (1) A little, (3) Somewhat, (4) A lot, Higher score denotes more attention

    Measured: Minute 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2026
  2. Study start27 May 2026
  3. Primary completion21 Jul 2026
  4. Study completion21 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Assign participants to view a cannabis edibles package with one of four variations of a warning and answer a series of questions assessing knowledge, harm perceptions, and willingness to try the product shown. One group will serve as the control and will see the same cannabis edibles package without a warning.
Masking
Single blind
Who is masked
Participant
Enrolment
1,250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07496489
Sponsor's protocol ID
IRB00146709
Other IDs
R01DA053209
Status last verified
Mar 2026
First submitted
20 Mar 2026
Last updated
13 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Delayed Effects Text Only, Delayed Effects Plus Icon and Delayed Effects Plus Dose in people with Cannabis Use, run by Wake Forest University Health Sciences at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Product appeal score (time frame: Minute 1). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in